Transforming regulatory overheads into actionable insights for pharmaceutical multinationals
The traditional world of Pharmacovigilance (PV) is experiencing a major change with increased patient awareness and emphasis on patient safety by regulatory health authorities.
We are deeply committed to helping pharmaceutical multinationals by addressing existing challenges as well as forestalling future issues. Our offering SMARTANCE is the next-gen, end-to-end completely integrated service that offers optimized processes across the clinical, regulatory and PV functions around the globe. Wipro’s wide range of PV automation solutions offer a significant reduction in case processing time, total cost of operations and increases complete quality compliance.
We want to go the extra mile by not only addressing the client’s regulatory compliance needs, but also by offering cutting-edge analytics that help in proactive risk assessment of their drugs, improve their distribution channels and fuel their R&D and clinical trials. By sharing a common clarity of purpose and with our unwavering commitment to our client’s cause, Wipro has been able to position its clients’ safety case processing on best in class trajectory.